Showing results (41-50 of 134) with videos related to
Sort By:
Pageof 14
The Israel Medical Association Journal : IMAJ|February 28, 2008
CD44 gene vaccination for insulin-dependent diabetes mellitus in non-obese diabetic miceLola Weiss, Ana Maria Botero-Anug, Carla Hand, et al.Cytokines, Cellular & Molecular Therapy|July 10, 2003
Intraportal and systemic allogeneic cell therapy in a murine model of hepatic metastatic breast cancerSoumya Panigrahi, Elena Yacovlev, Yael Gelfand, et al.EMBO Molecular Medicine|February 22, 2012
Novel telomerase-increasing compound in mouse brain delays the onset of amyotrophic lateral sclerosisErez Eitan, Ailon Tichon, Aviv Gazit, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 30, 2008
CpG-induced myeloid CD11b+Gr-1+ cells efficiently suppress T cell-mediated immunoreactivity and graft-versus-host disease in a murine model of allogeneic cell therapyShoshana Morecki, Yael Gelfand, Elena Yacovlev, et al.Cytotherapy|November 12, 2009
Telomerase activity and expression in adult human mesenchymal stem cells derived from amyotrophic lateral sclerosis individualsAilone Tichon, Basan K S Gowda, Shimon Slavin, et al.Current Stem Cell Research & Therapy|October 8, 2009
Repair of bone defect using bone marrow cells and demineralized bone matrix supplemented with polymeric materialsBasan Gowda S Kurkalli, Olga Gurevitch, Alejandro Sosnik, et al.Cancer Immunology, Immunotherapy : CII|March 11, 2020
Significant association between tumor mutational burden and immune-related adverse events during immune checkpoint inhibition therapiesCsaba Kerepesi, Tibor Bakacs, Ralph W Moss, et al.Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|September 28, 2002
Non-myeloablative stem cell transplantation for the treatment of cancer and life-threatening non-malignant disorders; past accomplishments and future goalsShimon Slavin, Mehmet Aker, Michael Y Shapira, et al.Journal of Clinical Immunology|May 10, 2002
Treatment of leukemia by alloreactive lymphocytes and nonmyeloablative stem cell transplantationShimon Slavin, Arnon Nagler, Michael Y Shapira, et al.Experimental Hematology|January 25, 2003
CD40 ligand-specific antibodies synergize with cyclophosphamide to promote long-term transplantation tolerance across MHC barriers but inhibit graft-vs-leukemia effects of transplanted cellsTatyana B Prigozhina, Olga Gurevitch, Gregory Elkin, et al.Pageof 14